No further details on this right now.
US$50bn is a substantial investment from the firm.
AstraZeneca plc is a British-Swedish pharmaceutical and biotechnology firm
- headquarters in Cambridge, UK
Visit investingLive.com (formerly ForexLive.com) for additional, original views.
This article was written by Eamonn Sheridan at investinglive.com.